secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-12-06T23:59:59+00:00
Accession:  0001493152-24-049099
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical dismisses Deloitte & Touche as independent auditor effective Dec. 2, 2024
--------------------------------------------------------------------------------

- Dismissed Deloitte & Touche LLP as independent registered public accounting firm effective December 2, 2024.
- No disagreements with Deloitte on accounting principles, financial statement disclosure, or audit scope during fiscal 2022–2023 or interim period through Dec. 2, 2024.
- Deloitte's prior reports contained a going concern explanatory paragraph citing working capital deficiency and anticipated losses.
- Board approved the change by written consent on December 2, 2024.
- Company requested Deloitte to furnish a letter to the SEC agreeing with the statements; letter attached as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224049099/0001493152-24-049099-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224049099/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-049099

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer